New stock news | Logistics company Siasun Robot & Automation's leading brand Kehlest has passed the listing hearing of the Hong Kong Stock Exchange. The products cover all indoor logistics scenarios.
The company offers a wide range of robot products centered around three core product lines: Multi-Directional Shuttle Robots (MSR), Autonomous Mobile Robots (AMR), and Conveyor Sorting Robots (CSR). The company's robot product portfolio has core functions of storage, sorting, and transportation, covering the entire scope of on-site logistics operations.
According to the disclosure of the Hong Kong Stock Exchange on March 8, Zhejiang Kai Le Shi Technology Group Co., Ltd. ("Kai Le Shi") had a listing hearing on the main board of the Hong Kong Stock Exchange, with GUOTAI JUNAN I and CITIC SEC as joint sponsors.
According to the prospectus, Kai Le Shi is a comprehensive provider of Siasun Robot & Automation products for intelligent intra-logistics. The company provides a variety of Siasun Robot & Automation products around three core product lines: multi-directional shuttle Siasun Robot & Automation (MSR), autonomous mobile Siasun Robot & Automation (AMR), and conveying sorting Siasun Robot & Automation (CSR). The company's Siasun Robot & Automation product portfolio has core functions for storage, sorting, and handling, covering the entire scope of intra-logistics operations.
Kai Le Shi's combination of Siasun Robot & Automation systems, intelligent software, and solution design expertise allows it to accurately match the unique requirements of each customer and transform capabilities into operational reality. This enables the company to provide solutions that meet the comprehensive needs of modern intra-logistics, from targeted deployment of Siasun Robot & Automation to full facility systems.
Financial data shows that Kai Le Shi's total revenues for the full year of 2022, 2023, and 2024 are expected to be RMB 657 million, RMB 551 million, and RMB 721 million, respectively, with revenues of RMB 552 million in the first three quarters of 2025.
Related Articles

GENSCRIPT BIO (01548) releases annual financial results, with a net loss attributable to shareholders of 533 million USD, a year-on-year shift from profit to loss.

SINOPEC SEG (02386) releases annual performance, shareholders' net profit of 1.798 billion yuan decreased by 27.1% year-on-year.

CITIC SEC: The impact of rising PET prices is controllable, and beverage companies are expected to reduce hedging costs.
GENSCRIPT BIO (01548) releases annual financial results, with a net loss attributable to shareholders of 533 million USD, a year-on-year shift from profit to loss.

SINOPEC SEG (02386) releases annual performance, shareholders' net profit of 1.798 billion yuan decreased by 27.1% year-on-year.

CITIC SEC: The impact of rising PET prices is controllable, and beverage companies are expected to reduce hedging costs.






